Press release
Uveitis Market to Exhibit Rapid Growth Rate During the Forecast Period (2023-2032), Investigates DelveInsight | Tarsier Pharma, Roche, Eli Lilly and Company, Oculis, Acelyrin/ Affibody Medical, Eli Lilly
To Know in detail about the Uveitis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Uveitis Market Forecast
https://www.delveinsight.com/sample-request/uveitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Uveitis Market Report:
• The Uveitis market size was valued USD 1,496 Million in 2022 and is anticipated to grow with a significant CAGR during the study period (2019-2032)
• According to DelveInsight data, there were approximately 1,013,902 diagnosed prevalent instances of uveitis in the 7MM as of 2022. This number is anticipated to rise to 2032 at a CAGR of 0.23% for the study period (2019-2032)
• Nearly 38% of all diagnosed prevalent instances of uveitis in the 7MM were located in the US in 2022, and this percentage is projected to rise even more by 2032
• In the EU4 and the UK, idiopathic uveitis accounted for the majority of cases-roughly 148,417-followed by other (111,152 cases), sarcoidosis (33,567 cases), HLA-B27-associated uveitis (26,614 instances), and other aetiologies in 2022. By 2032, these latter are predicted to become more common
• Key Uveitis Companies: Tarsier Pharma, Roche, Eli Lilly and Company, Oculis, Acelyrin/ Affibody Medical, Eli Lilly and Company, Priovant Therapeutics, EyePoint Pharmaceuticals, Inc., ACELYRIN Inc., Bio-Thera Solutions, Clearside Biomedical, Inc., Eli Lilly and Company, ACELYRIN Inc., AbbVie, The Emmes Company, LLC, Merrimack Pharmaceuticals, Allergan, Novartis, and others
• Key Uveitis Therapies: TRS01, RG6179, Baricitinib, OCS-02, Izokibep, Baricitinib, Brepocitinib, Sham Injector, Izokibep, QLETLI, triamcinolone acetonide (Triesence®), Baricitinib, Izokibep, Adalimumab, B27PD, MM-093, Dexamethasone pellet, AEB071, and others
• The Uveitis epidemiology based on gender analyzed that noninfectious uveitis cases are higher in number than infectious uveitis cases
• The Uveitis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Uveitis pipeline products will significantly revolutionize the Uveitis market dynamics.
Uveitis Overview
The term "uveitis" refers to a broad range of inflammatory eye illnesses. The middle layer of the eye wall, or uvea, can become inflamed in cases of uveitis, according to the National Cancer Institute.
Get a Free sample for the Uveitis Market Report
https://www.delveinsight.com/report-store/uveitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Uveitis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Uveitis Epidemiology Segmentation:
The Uveitis market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Uveitis
• Prevalent Cases of Uveitis by severity
• Gender-specific Prevalence of Uveitis
• Diagnosed Cases of Episodic and Chronic Uveitis
Download the report to understand which factors are driving Uveitis epidemiology trends @ Uveitis Epidemiology Forecast
https://www.delveinsight.com/sample-request/uveitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Uveitis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Uveitis market or expected to get launched during the study period. The analysis covers Uveitis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Uveitis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Uveitis Therapies and Key Companies
• TRS01: Tarsier Pharma
• RG6179: Roche
• Baricitinib: Eli Lilly and Company
• OCS-02: Oculis
• Izokibep: Acelyrin/ Affibody Medical
• Baricitinib: Eli Lilly and Company
• Brepocitinib: Priovant Therapeutics
• Sham Injector: EyePoint Pharmaceuticals, Inc.
• Izokibep: ACELYRIN Inc.
• QLETLI: Bio-Thera Solutions
• triamcinolone acetonide (Triesence®): Clearside Biomedical, Inc.
• Baricitinib: Eli Lilly and Company
• Izokibep: ACELYRIN Inc.
• Adalimumab: AbbVie
• B27PD: The Emmes Company, LLC
• MM-093: Merrimack Pharmaceuticals
• Dexamethasone pellet: Allergan
• AEB071: Novartis
Discover more about therapies set to grab major Uveitis market share @ Uveitis Treatment Market
https://www.delveinsight.com/sample-request/uveitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Uveitis Market Strengths
• New drugs with diverse mechanisms of action and administration routes have been approved recently, improving the treatment regime
• Advances in disease nomenclature for classification, clinical trials, drug delivery systems, multimodality diagnostic imaging, and laboratory testing involving "omics" technology have provided insight into disease pathogenesis
Uveitis Market Opportunities
• Biomarker discovery and proteomics provide potential targets for therapeutic intervention by the drugs that are available and accessible, besides providing information about the drug that can be avoided.
• Opportunity for companies to implement knowledge from recent advances in understanding the etiologies associated with uveitis to evaluate potential drugs with novel targets.
Scope of the Uveitis Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Uveitis Companies: Tarsier Pharma, Roche, Eli Lilly and Company, Oculis, Acelyrin/ Affibody Medical, Eli Lilly and Company, Priovant Therapeutics, EyePoint Pharmaceuticals, Inc., ACELYRIN Inc., Bio-Thera Solutions, Clearside Biomedical, Inc., Eli Lilly and Company, ACELYRIN Inc., AbbVie, The Emmes Company, LLC, Merrimack Pharmaceuticals, Allergan, Novartis, and others
• Key Uveitis Therapies: TRS01, RG6179, Baricitinib, OCS-02, Izokibep, Baricitinib, Brepocitinib, Sham Injector, Izokibep, QLETLI, triamcinolone acetonide (Triesence®), Baricitinib, Izokibep, Adalimumab, B27PD, MM-093, Dexamethasone pellet, AEB071, and others
• Uveitis Therapeutic Assessment: Uveitis current marketed and Uveitis emerging therapies
• Uveitis Market Dynamics: Uveitis market drivers and Uveitis market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Uveitis Unmet Needs, KOL's views, Analyst's views, Uveitis Market Access and Reimbursement
To know more about Uveitis companies working in the treatment market, visit @ Uveitis Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/uveitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1. Uveitis Market Report Introduction
2. Executive Summary for Uveitis
3. SWOT analysis of Uveitis
4. Uveitis Patient Share (%) Overview at a Glance
5. Uveitis Market Overview at a Glance
6. Uveitis Disease Background and Overview
7. Uveitis Epidemiology and Patient Population
8. Country-Specific Patient Population of Uveitis
9. Uveitis Current Treatment and Medical Practices
10. Uveitis Unmet Needs
11. Uveitis Emerging Therapies
12. Uveitis Market Outlook
13. Country-Wise Uveitis Market Analysis (2019-2032)
14. Uveitis Market Access and Reimbursement of Therapies
15. Uveitis Market Drivers
16. Uveitis Market Barriers
17. Uveitis Appendix
18. Uveitis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Related Reports:
Uveitis Pipeline https://www.delveinsight.com/report-store/uveitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"Uveitis Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Uveitis market. A detailed picture of the Uveitis pipeline landscape is provided, which includes the disease overview and Uveitis treatment guidelines.
Uveitis Epidemiology https://www.delveinsight.com/report-store/uveitis-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Uveitis Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Uveitis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports by DelveInsight
Monkeypox Market https://www.delveinsight.com/report-store/monkeypox-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Monkeypox Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Monkeypox, historical and forecasted epidemiology as well as the Monkeypox market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Pars Planitis Market
https://www.delveinsight.com/report-store/pars-plantis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Pars Plantis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Pars Plantis, historical and forecasted epidemiology as well as the Pars Plantis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Patient Monitoring Devices Market
https://www.delveinsight.com/report-store/patient-monitoring-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Patient Monitoring Devices Market By Type Of Devices (Neuromonitoring Devices, Cardiac Monitoring Devices, Respiratory Monitoring Devices, Hemodynamic Monitoring Devices, Blood Glucose Monitoring Systems, And Others), By Application (Cardiology, Neurology, Respiratory, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings, And Others), by geography, is anticipated to grow at a significant CAGR till 2028 owing to the growing prevalence of various chronic disorders and integration of advanced technology in the products
Typhoid Market https://www.delveinsight.com/report-store/typhoid-fever-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Typhoid Fever Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Typhoid Fever, historical and forecasted epidemiology as well as the Typhoid Fever market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Zika Virus Market https://www.delveinsight.com/report-store/zika-virus-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Zika Virus Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Zika Virus, historical and forecasted epidemiology as well as the Zika Virus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Opioid Use Disorder Market https://www.delveinsight.com/report-store/opioid-use-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Opioid Use Disorder (OUD) - Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Opioid Use Disorder (OUD), historical and forecasted epidemiology as well as the Opioid Use Disorder (OUD) market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.
Recent Blog's By DelveInsight:
• Insights Into The Cutaneous T-cell Lymphoma Treatment Market
https://www.delveinsight.com/blog/cutaneous-t-cell-lymphoma-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Roche's HEMLIBRA: A Game Changer in Hemophilia A Treatment Landscape
https://www.delveinsight.com/blog/hemlibra-for-hemophilia-a-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Emerging Role of Digital Health in the Field of Oncology
https://www.delveinsight.com/blog/digital-health-to-improve-cancer-management?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How Will Emerging Therapies Drift the Amyotrophic Lateral Sclerosis (ALS) Treatment Landscape
https://www.delveinsight.com/blog/evolving-als-treatment-landscape?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How are Technological Trends and Innovations Reshaping the Dementia Care
https://www.delveinsight.com/blog/technological-innovations-in-dementia-care?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Assessing the Major Growth and Ongoing Developments in the Clinical Diagnostics Market
https://www.delveinsight.com/blog/clinical-diagnostics-market-outlook?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Non-opioid Analgesics Chronic Pain Treatment: Savior of Underserved Patients
https://www.delveinsight.com/blog/non-opioid-analgesics-for-chronic-pain-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Limited Availability and Lack of Access are Unlikely to Hinder the Billion-Dollar Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market
https://www.delveinsight.com/blog/alpha-1-antitrypsin-deficiency-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Evaluating the Key Trends and Technologies Shaping the Future of Dentistry https://www.delveinsight.com/blog/emerging-trends-in-dental-care-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Uveitis Market to Exhibit Rapid Growth Rate During the Forecast Period (2023-2032), Investigates DelveInsight | Tarsier Pharma, Roche, Eli Lilly and Company, Oculis, Acelyrin/ Affibody Medical, Eli Lilly here
News-ID: 3134086 • Views: …
More Releases from DelveInsight Business Research
Global General Surgery Devices Market is expected to grow at a CAGR of 6.3% by 2 …
General Surgery Devices Market Overview
The Global General Surgery Devices Market is projected to grow at a CAGR of 6.34% from 2025 to 2032, driven by the rising burden of chronic diseases, increasing surgical interventions, and the adoption of robotic-assisted and minimally invasive techniques. Covering instruments such as handheld tools, electrosurgical devices, laparoscopic systems, wound closure products, and disposables, these devices play a critical role in diverse procedures, including orthopedic, cardiovascular,…
Intratumoral Cancer therapies Market Outlook 2034 - Clinical Trials, Market Size …
Intratumoral Cancer Market Summary
Intratumoral cancer therapies involve direct delivery into tumors, enabling localized targeting with minimal damage to surrounding tissue. Within the 7MM, non-melanoma cancers represent the largest share of cases and are expected to rise at ~2% annually, while in the US, breast cancer accounts for about 30% of cases with a growing incidence rate for intratumoral therapies. Currently, IMLYGIC is the only FDA-approved intratumoral therapy for melanoma, holding…
Bispecific and Trispecific Antibodies Market Projected to Experience Significant …
Bispecific antibodies represent an innovative class of therapies designed to address complex diseases by simultaneously binding two targets with a single molecule. Most currently approved bispecifics are for oncology, particularly multiple myeloma and diffuse large B-cell lymphoma (DLBCL). Beyond oncology, only HEMLIBRA and VABYSMO are approved for conditions such as hemophilia A, wet age-related macular degeneration, and diabetic macular edema, while KIMMTRAK is approved for uveal melanoma. The pipeline remains…
Narcolepsy Pipeline 2025: Therapies, MOA Insights, and Key Clinical Trial Update …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Narcolepsy pipeline constitutes 10+ key companies continuously working towards developing 12+ Narcolepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Narcolepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed…
More Releases for Uveitis
Uveitis Market : An Overview Report
Introduction:
Uveitis is an inflammatory condition affecting the uvea, the middle layer of the eye. It can lead to vision impairment or even blindness if left untreated. Uveitis is categorized into different types, including anterior, intermediate, posterior, and panuveitis, depending on the part of the eye affected. The condition can be caused by infections, autoimmune diseases, or trauma. With increasing cases of autoimmune disorders and infectious diseases, the prevalence of uveitis…
Uveitis Treatment Market Size, Share | Trend 2030
Exclusive Report by Ameco Research: Uveitis Treatment Market Size Projected to Reach USD 2 Billion by 2030, Growing at 6% CAGR
Ameco Research is proud to announce the launch of its latest market research report, Uveitis Treatment Market. This comprehensive report provides in-depth analysis and insights into the current market trends and future projections in the Industry/Market Segment. Ameco Research has been at the forefront of providing quality market research…
Uveitis - Drug Pipeline Landscape, 2022
New York, Global Insight Services have recently published a report on Uveitis - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.
Uveitis is an inflammation of the eye which damages the part of the eye called the uvea and affects other parts of the eyes which causes pain to the eyes. There are 4 types of…
Uveitis - Drug Pipeline Landscape, 2022
Global Insight Services have recently published a report on Uveitis - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.
Uveitis is an inflammation of the eye which damages the part of the eye called the uvea and affects other parts of the eyes which causes pain to the eyes. There are 4 types of uveitis based…
Japan Industry Statistics of Uveitis Treatment
Global Uveitis Treatment Market: Overview
Uveitis, an autoimmune eye disease, is considered rare for just around 38 in 100,000 people are afflicted by it. Because of this, it is often overlooked. Patients afflicted by uveitis are often referred to an expert after much delay on account of less awareness about the eye malady. This delays timely diagnosis and results in irreversible damage to various ocular structures.
Read Report Overview: https://www.transparencymarketresearch.com/uveitis-treatment-market.html
As per Cochrane,…
Uveitis Treatment Market Analysis of Top industry Scenario
Global Uveitis Treatment Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables).
According to a new report published by Allied Market Research, titled, "Uveitis Treatment Market by Drug Class (Anti-inflammatory, Antimicrobial Drugs, Immunotherapy &…
